SAKDC - DAVITA DIALYSIS PARTNERS LP
NPI: 1851354880
· FLORESVILLE, TX 78114
· End-Stage Renal Disease (ESRD) Treatment Clinic/Center
· NPI assigned 04/10/2006
Billing Flags
· Automated signals — not evidence of fraud
Entity Proliferation
Authorized official WEY, SAM controls 14+ related entities in our dataset. Read more
$0.00
Total Medicaid Paid
Provider Details
| Authorized Official | WEY, SAM (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/10/2006 |
Related Entities
Other providers sharing the same authorized official: WEY, SAM
Monthly Spending Trend
Yearly Breakdown
| Year | Claims | Total Paid |
| 2021 |
5,918 |
$0.00 |
| 2022 |
3,185 |
$0.00 |
| 2023 |
232 |
$0.00 |
Billing Codes
| Code | Description | Claims | Beneficiaries | Total Paid |
| 85048 |
|
347 |
343 |
$0.00 |
| 84466 |
|
388 |
377 |
$0.00 |
| 85041 |
|
377 |
368 |
$0.00 |
| 83970 |
|
270 |
254 |
$0.00 |
| 83540 |
|
420 |
401 |
$0.00 |
| 85045 |
|
342 |
332 |
$0.00 |
| 82108 |
|
135 |
127 |
$0.00 |
| 82728 |
|
435 |
413 |
$0.00 |
| A4657 |
Syringe, with or without needle, each |
467 |
438 |
$0.00 |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
42 |
34 |
$0.00 |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
5,798 |
363 |
$0.00 |
| 82607 |
|
147 |
139 |
$0.00 |
| 82746 |
|
147 |
139 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
20 |
20 |
$0.00 |